Evidence map›Paper›PMID 39833939›Full record

ArticleVeterinary research2025

Baicalein inhibits PRRSV through direct binding, targeting EGFR, and enhancing immune response.

Jing Wu, Qi Lu, Jing Hou, Yueqin Qiu, Min Tian, Li Wang, Kaiguo Gao, Xuefen Yang, Zongyong Jiang

Abstract read
In one paragraph

Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing Wu *Institute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Qi Lu *Institute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Jing HouInstitute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Yueqin QiuInstitute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Min TianInstitute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Li WangInstitute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Kaiguo GaoInstitute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.
Xuefen YangInstitute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China. yangxuefen@gdaas.cn.ORCID http://orcid.org/0000-0003-3144-2939
Zongyong JiangInstitute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China.

Funding

Earmarked Fund for China Agriculture Research System CARS-35Guangzhou Municipal Science and Technology Program key projects 202206010193National Key R&D Program of China 2021YFD1300402Special Fund for Rural Revitalization Strategy of Guangdong 2024TS-3-1Special Fund for Scientific Innovation Strategy-Construction of High-level Academy of Agriculture Science R2023PY-JG013
6 · The paper itself

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) presents significant economic challenges to the global pork industry due to its ability to mutate rapidly. The current commercial vaccines have limited effectiveness, and there are strict restrictions on the use of antiviral chemical drugs. Therefore, it is urgent to identify new strategies for preventing and controlling PRRSV infections. Baicalein, a flavonoid derived from Scutellaria baicalensis, has gained attention for its potential antiviral properties. However, there is little information about the effects and mechanisms of baicalein in relation to PRRSV. In this study, a network pharmacology analysis identified seven potential targets of baicalein against PRRSV, with the epidermal growth factor receptor (EGFR) emerging as the core target. The results of molecular docking and dynamics (MD) simulations confirmed that baicalein has a high binding affinity for EGFR, with a measured value of - 7.935 kcal/mol. Additionally, both in vitro (EC

Indexed as

Antiviral AgentsErbB ReceptorsFlavanonesPorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusAnimalsMolecular Docking SimulationSwineVirus ReplicationAntiviral AgentsbaicaleinErbB ReceptorsFlavanonesbaicaleinEGFRMD simulationPigletsPRRSV

Identifiers

PMID39833939
PMCPMC11748510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.